Introduction In clinical practice, effective and clear communication is essential to the physician patient. Original Article

Size: px
Start display at page:

Download "Introduction In clinical practice, effective and clear communication is essential to the physician patient. Original Article"

Transcription

1 412 Journal of Pain and Symptom Management Vol. 25 No. 5 May 2003 Original Article Breast Cancer Patient Perception of the Helpfulness of a Prompt Sheet Versus a General Information Sheet During Outpatient Consultation: A Randomized, Controlled Trial Eduardo Bruera, MD, Catherine Sweeney, MB, Jie Willey, RN, MSN, J. Lynn Palmer, PhD, Susanne Tolley, RN, Marguerite Rosales, MD, and Carla Ripamonti, MD Departments of Symptom Control and Palliative Care (E.B., C.S., J.W., J.L.P., S.T.) and Breast Medical Oncology (M.R.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; and Rehabilitation and Palliative Care Division (C.R.), National Cancer Institute, Milan, Italy Abstract The purpose of this study was to determine the helpfulness of a prompt sheet versus a general information sheet for patient communication with physicians. Sixty women with breast cancer attending their first outpatient consultation with a breast medical oncologist were randomized to receive either a prompt sheet (PS) or a general information (GI) sheet regarding breast cancer. Analysis of the results found that helpfulness of the written material was rated higher in the PS group (8.5 2) than the GI group ( ), P The mean score of helpfulness in communicating with physicians was and , respectively, P There were no significant differences between the groups in the average total number of questions asked by the patients or average physician or patient speaking time. We conclude that a disease-specific prompt sheet provided before medical encounters may assist in communication between patients and physicians. J Pain Symptom Manage 2003;25: U.S. Cancer Pain Relief Committee. Published by Elsevier. All rights reserved. Key Words Breast cancer, prompt sheet, communication Introduction In clinical practice, effective and clear communication is essential to the physician patient Address reprint requests to: Eduardo Bruera, MD, Department of Palliative Care and Rehabilitation Medicine, Box 8, U.T. M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. Accepted for publication: July 16, relationship. 1 Moreover, better communication can translate into improved patient satisfaction. 2 Given the increased incidence of breast cancer over the last few years and the estimated 192,200 new cases of breast cancer expected in the United States in 2001, 3 the type and quality of communication between breast cancer patients and their physicians will impact many people. Improved communication will not only affect the patients quality of care, mechanisms for coping, and compliance with treatments but 2003 U.S. Cancer Pain Relief Committee /03/$ see front matter Published by Elsevier. All rights reserved. doi: /s (02)

2 Vol. 25 No. 5 May 2003 Breast Cancer Prompt Sheet 413 will also likely affect the success of individual physicians and health care facilities. Several approaches have been proposed for improving communication between patients and physicians, including giving patients a letter summarizing the consultation 4 and giving patients a tape recording of the consultation. 5 8 In a recent randomized controlled trial, 8 we found that giving patients an audiocassette in addition to written communication significantly increased patient satisfaction with an oncology clinic and significantly improved recall of the information received during the consultation. Audiocassettes and written information are currently used regularly during patient visits in the Department of Palliative Care and Rehabilitation Medicine at our institution. However, one of the limitations of this approach is that although patients receive reinforcement of discussions that take place during the clinic visit, the approach does not ensure that patients ask those questions that are of greatest concern to them. Two preliminary studies by an Australian group suggest that giving patients prompt sheets with suggested questions might be helpful in enhancing communication during consultations. 9,10 Butow et al. randomized 142 cancer patients to receive a question prompt sheet (PS) or a general information sheet (GI). 9 They found that the prompt sheet did not influence the total number of questions asked and the duration of patient talk. Brown et al. randomized 60 cancer patients to receive either a PS or a standard consultation. 10 They observed an increased number of questions asked in the PS group. Both of these studies assessed only global satisfaction with the clinic instead of specifically assessing the prompt sheet. Their studies found extremely high level of global satisfaction in both intervention and control groups and there was no significant difference. 9,10 The authors of one of the of the studies concluded that the prompt sheet had limited value. 9 Despite the literature showing that global satisfaction is usually rated very highly, 9 11 there is evidence that communication between patients and doctors can directly affect patient satisfaction outcomes. Unfortunately, patient expectations are frequently not met and patients are often not satisfied with information received Communication may be better when patients are able to ask their most meaningful questions rather than just more questions. In the current study, we randomized patients with breast cancer to receive either a prompt sheet or a general information sheet regarding breast cancer before their consultation with breast medical oncologists. Our primary goal was to specifically determine how helpful patients found the prompt sheet as compared to the general information sheet. Methods Patient Selection The study was performed in the Breast Center at the University of Texas M.D. Anderson Cancer Center. To be included in the study, patients had to have pathologically confirmed breast cancer, be 18 years old, and be attending their first outpatient consultation with a breast medical oncologist. They also had to have a normal cognitive status, defined as a normal state of arousal and an absence of obvious clinical findings of confusion, memory deficits or concentration deficits, be able to communicate in English, and have signed a written informed consent form. When the research nurse identified a potentially eligible patient, the attending physician was informed and asked to give verbal consent for the patient s participation in the study. Patients then provided written consent to participate in the study and were randomly given an envelope by the research nurse while they waited for their visit. The envelope contained written information of either a PS or a GI regarding breast cancer. The research nurse was blinded as to the patient s randomization. Clinicians who saw the patients in their clinic were not instructed to respond to neither the PS nor the GI. To prevent patient bias, we did not disclose which of the 2 interventions we thought would be most likely to improve communication. Our consent form was written to reflect this need, which was disclosed to the patients. Design of Prompt Sheet The initial draft for the prompt sheet was based on previous studies 9,10,13 and other suggestions. 14 Modifications included the addition of extra questions, some minor changes based on the audiocassette study results 8 and the clinical experience of the faculty in the Department of Palliative Care and Rehabilitation Medicine and the Department of Breast Medi-

3 414 Bruera et al. Vol. 25 No. 5 May 2003 cal Oncology at the M. D. Anderson Cancer Center. The prompt sheet contained 22 breast cancer diagnosis, treatment, and prognosis-related questions. In addition, space for new questions was added. After discussions with the co-investigators and the faculty of the Department of Breast Medical Oncology, the content was once again modified, and a final prompt sheet was designed (Appendix 1). Design of General Information Sheet The information sheet is enclosed as Appendix 2. This sheet was created by the faculty and staff of the Breast Center, the University of Texas M. D. Anderson Cancer Center. The general information sheet was summarized so as to be able to be read comfortably during the period of time patients and families wait before being seen by one of the physicians and/or nurses. Based on the experience of the breast cancer oncologists and nurses we summarized the area that is usually considered of highest relevance for them from their booklet. 17,18 Procedures The consultation between the patient and the physician was recorded on an audiocassette. At the end of the visit, the research nurse (not present during the consultation and blinded to the type of written material given) gave the patient a questionnaire for completion that dealt with aspects of the consultation and information package (Appendix 3). A physician evaluation form was presented to the physician who was also blinded as to the type of written material given at the time. The physician evaluation form consisted of 2 statements: 1) Overall, I am satisfied with the way I was able to communicate with my patient (assessed by a numerical rating scale of 0 to 10); and 2) The duration of visit compared to my expectation (a multiple choice was given to determine whether the visit was much longer, a little longer, no longer or shorter, a little shorter, or much shorter than expected). The following information was collected from the audiocassette by the research nurse: 1) total duration of the visit in minutes; 2) amount of time during which the physician spoke; 3) amount of time during which the patient spoke; 4) total number of questions asked by the patient and relatives; and 5) the category of each question asked, namely, diagnosis, treatment, prognosis, or other. Finally, the research nurse reviewed the patient s chart and collected information regarding diagnosis, demographics, and other patient characteristics. Statistical Considerations The primary outcome measures included patient rating of helpfulness of the information package and satisfaction with communication during the clinic visit. Our hypothesis was that patients receiving the prompt sheet would show higher helpfulness and satisfaction ratings than patients who received the general information sheet. To test these hypotheses, analyses of variance models were tested using patient satisfaction scores as dependent variables and treatment group as a predictor. Differences between groups in demographic variables were tested to determine if the variables should be added as covariates in the models. Secondary outcomes, such as duration of the clinic visit and the number of questions asked were evaluated in a similar fashion. Results Of 132 patients screened for the study, 60 women with breast cancer were enrolled. Thirty women received the prompt sheet (PS) and 30 received the general information sheet (GI). Figure 1 summarizes the patient accrual process. Fig. 1. Patient Accrual. *Twenty-seven patients did not speak English, 7 had no pathologic confirmation of breast cancer, 1 had history of anxiety, 16 patients previously treated at M.D. Anderson Cancer Center, 9 patients were not consented due to time constraints.

4 Vol. 25 No. 5 May 2003 Breast Cancer Prompt Sheet 415 Characteristic Table 1 Demographic and Clinical Characteristics of Patients No. of Patients in GI Group (%) No. of Patients in PS Group (%) Total Patients (%) Overall 30 (50) 30 (50) 60 (100) Mean Age, years (range) 54 (37 80) 53.4 (26 80) (26 80) Race/Ethnicity Black 1 (3) 0 (0) 1 (2) White 26 (87) 28 (93) 54 (90) Asian 1 (3) 1 (3) 2 (3) Hispanic 2 (7) 1 (3) 3 (5) Educational Level Under 12th grade 1 (3) 1 (3) 2 (3) High school graduate 10 (33) 9 (30) 19 (32) College or higher 19 (64) 20 (67) 39 (65) Occupation Professional 10 (33) 8 (27) 18 (30) Business 6 (20) 4 (13) 10 (17) Clerk and secretary 6 (20) 8 (27) 14 (23) Labor 1 (3) 0 (0) 1 (2) Homemaker 7 (24) 10 (33) 17 (28) Martial Status Married 24 (80) 19 (63) 43 (72) Single 1 (3) 2 (7) 3 (5) Divorced/Separated 4 (14) 5 (17) 9 (15) Widowed 1 (3) 4 (13) 5 (8) House Income Less than $50, (37) 11 (37) 22 (37) $50, , (50) 12 (40) 27 (45) Above $100,000 1 (3) 1 (3) 2 (3) Declined to answer 3 (10) 6 (20) 9 (15) Current Stage Local/regional 20 (67) 17 (57) 37 (62) Metastatic 10 (33) 13 (43) 23 (38) Time Since Diagnosis 2 months 15 (50) 15 (50) 30 (50) 2 months 15 (50) 15 (50) 30 (50) Prior Treatment Surgery 15 (50) 9 (30) 24 (40) Systemic therapy 1 (3.3) 0 1 (1.6) None 3 (10) 12 (40) 15 (25) Surgery radiation 1 (3.3) 0 1 (1.6) Surgery systemic therapy 3 (10) 3 (10) 6 (10) Radiation systemic therapy 1 (3.3) 0 1 (1.6) Surgery radiation systemic therapy 6 (20) 6 (20) 12 (20) Table 1 shows the demographic and clinical characteristics of the patients. Their mean age was 54 years (range years); most patients in both groups were white, were married, and had some college or completed college degree. Twenty-eight (47%) of 60 patients were professionals or businesswomen, and 17 (28%) were homemakers. Twenty-nine patients (48%) reported household income more than $50,000. Thirty-seven patients (62%) had local or regional disease. The time since diagnosis of breast cancer was at least 2 months for 30 patients (50%). No statistically significant differences were found between the groups for demographic variables. Table 2 reports the results of the patient questionnaire. The mean overall helpfulness rating (a numerical rating scale 0 to 10) of the written material was significantly higher in the PS group (8.5) than GI group (6.2), P The mean helpfulness of the written material in communicating with physicians was 7.9 for the PS group and 5.7 for GI group, P Overall satisfaction with the consultation, satisfaction with the communication with the doctor, and satisfaction with the ability of the doctor to answer the patients questions were very high in both groups (no significant differences).

5 416 Bruera et al. Vol. 25 No. 5 May 2003 Table 2 Results of Patient Satisfaction Survey Variable Rating by Patients in GI Group, mean (SD) Rating by Patients in PS Group, mean (SD) P value Helpfulness of written material 6.20 (3.65) a 8.47 (2.08) Written material helped to communicate with the doctor 5.70 (3.79) 7.90 (2.37) Overall satisfaction of communication with the doctor 9.07 (1.33) 9.23 (1.33) Satisfaction with the consult 9.03 (1.67) 8.70 (1.62) Doctor was able to answer all the questions 9.30 (1.39) 8.90 (1.72) Will use similar written material in the future 7.87 (3.03) 8.93 (1.68) a 0 completely disagree; 10 completely agree. Table 3 reports the results of consultation recordings. Only the number of questions on diagnosis differed between the two groups: 2.5 (PS) group vs. 1.4 (GI) group, P The average total number of questions asked by the patients was not significantly different between the 2 groups and the average physician and patients speaking times were also not significantly different. All other differences between the groups were not statistically significant. Patients in both groups asked more questions related to treatment (5.08 for the PS group, 6.66 for the GI group) than to any other category, and they both asked fewest prognosis-related questions ( and , respectively). The physicians were blinded with respect to the written material received by the patients and reported no difference in satisfaction with the way they were able to communicate with their patients (9.4 for the PS group vs. 9.1 for the GI group). In 40 cases (67%), the physician estimated that the consultation duration was not longer or shorter than expected, and this result was not significantly different between the PS group and the GI group. Discussion In this randomized, controlled trial we found that the administration of a prompt sheet had significant effects on patient helpfulness ratings of the written material provided and of communication with the doctor when compared to the general information sheet. The prompt sheet was perceived by patients as helpful for communication without significantly increasing the length of the physician or patient speaking time or the total number of questions asked during the visit. Our findings suggest that these patients were able to ask questions that better address their main concerns rather than simply asking more questions. One possible alternative explanation is that although patients perceived the material to be helpful, communication was not more effective. This question can be resolved in future studies by asking beforehand patient s critical questions and monitoring if they were actively addressed during the interview. In our study, the fact that speaking times were not different between the 2 groups suggests that using a prompt sheet in regular clinical care can improve communication quality without increasing cost of care. Overall patient Table 3 Results of Audiocassette Recording Variable GI Group, mean (SD) PS Group, mean (SD) P value Consultation duration in minutes (47) (53) Number of questions asked by the patient 8.65 (5.28) (7.46) Minutes the patient spoke 5.58 (5.09) 5.45 (6.12) Minutes the doctor spoke (20.62) (21.42) Number of questions on diagnosis 1.38 (1.36) 2.45 (1.97) Number of questions on treatment 5.08 (3.50) 6.66 (4.56) Number of questions on prognosis 0.62 (1.02) 1.03 (1.21) Number of questions on other issues 4.00 (3.07) 4.60 (3.90) 0.519

6 Vol. 25 No. 5 May 2003 Breast Cancer Prompt Sheet 417 satisfaction with the clinic was extremely high and there was no significant difference between the 2 groups. The general information sheet used in the study was an established preexisting tool developed and used regularly by breast cancer specialists in our institution. Median satisfaction and helpfulness ratings in the control group indicate that patients found it useful. When Brown et al. studied the use of a prompt sheet during a standard consultation in a randomized controlled trial of 60 patients with heterogeneous cancers, the prompt sheet significantly increased the total number of questions asked and the number of questions asked regarding tests and treatment. 10 This study may have been biased as enrolled patients had higher levels of education than the general population. Butow et al. did not find any increase in the number of questions asked by the prompt sheet group. 9 The addition of one-on-one intensive coaching with a psychologist before the initial oncology consulta tion during which prompt sheet was used did not further increase the number of questions asked. The authors also tested global satisfaction in their study and found no significant difference between the 2 groups. In a recent study patients who received a prompt sheet had longer consultations and asked more questions as compared to those who did not. 15 The consultation duration was decreased when oncologists specifically addressed the prompt sheet. Our results are consistent with others in the literature in that satisfaction did not correlate well with the number of questions or speaking times. 9,10 However, the effect of the use of a prompt sheet on duration of the consultation needs to be clarified in future research. If researchers in other patient population confirm our findings, clinicians will be able to administer disease-specific prompt sheets to their patients without fear that this will result in excessive demands on their clinical time. Patients in our study asked a mean of 9 10 questions per consultation, similar to the 8 11 questions observed by Brown et al. 10 Patients who were given the prompt sheet asked significantly more questions about diagnosis than patients who were given the general information sheet. Other studies of prompt sheet use have produced similar findings. 9,10 A limitation of our study is that the design did not allow for testing of recall of information by patients. However, recall of information was not the main purpose as patients may have excellent recall of information that is not of relevance to them. The purpose of the prompt sheet was to help patients and their family to formulate questions that were relevant to them. A recent study has suggested that patients who have a prompt sheet addressed by their oncologist recall significantly more information and have less anxiety than those who have been given a prompt sheet alone. 15 This area should be clarified through further research. Future research should address improving patient information regarding diagnosis that could result in increased satisfaction with communication. The lack of questions about potentially difficult issues such as prognosis in both groups (median of 0 to 1 question asked) was probably due to the fact that we were studying a first consultation and its focus was mostly treatment decisions. It is likely that the types of questions asked during follow up visits or by patients with more advanced disease would be different than those found in our study. Therefore, these issues should also be addressed in future research. In previously published studies, the total number of questions asked seems to be less for male patients than female patients. 9,16 Butow et al. reported a mean of questions asked by women as compared to questions asked by men (P ). The duration of communication was also shorter for male patients. 9 Since men s question asking behavior appears to be lower than women s, future research should also address whether or not a prompt sheet can increase question asking by male patients and improve men s ability to plan their questions. We conclude that a disease specific prompt sheet provided before medical encounters is perceived to significantly assist in communications between patients and doctors and may not increase the overall number of questions asked or the duration of the physician or patient speaking time. Our findings need to be reproduced in patients with other chronically illness since similar beneficial results can likely be derived in these patient populations.

7 418 Bruera et al. Vol. 25 No. 5 May 2003 References 1. Morrow GR, Hoagland AC, Carpenter PJ. Improving physician-patient communications in cancer treatment. Psychosocial Oncology 1983;1/2: Kaplan SH, Ware J. The patient s role in health care and quality assessment. In: Goldfield N, Nash DB, eds. Providing quality care. Ann Arbor: Health Administration Press, 1995: Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics Cancer J Clin 2001;51: Damion D, Tattersall MHN. Letters to patients: improving communication in cancer care. Lancet 1991;338: Dunn SM, Butow PN, Tattersall MHN, et al. General information tapes inhibit recall of the cancer consultation. J Clin Oncol 1993;11: Hogbin B, Fallowfield L. Getting it taped: the bad news consultation with cancer patients. Br J Hosp Med 1989;41: Tattersall MHN, Butow PN, Griffin AM, Dunn SM. The take home message: patients prefer consultation audiotapes to summary letters. J Clin Oncol 1994;12: Bruera E, Pituskin E, Calder K, et al. The addition of an audiocassette recording of a consultation to written recommendations for patients with advanced cancer: a randomized, controlled trial. Cancer 1999;86: Butow PN, Dunn SM, Tattersall MHN, Jones QJ. Patient participation in the cancer consultation: evaluation of a question prompt sheet. Ann Oncol 1994;5: Brown R, Butow PN, Boyer MJ, Tattersall MHN. Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question asking. Br J Cancer 1999;80: Kravita RL, Cope DW, Bhrany V, Leake B. Internal medicine patients expectations for care during office visit. J General Inter Med 1994;9: Ong LM, DeHaes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med 1995;40: Ley P. Communication with patients: improving communication, satisfaction and compliance. London: Chapman and Hall, Kutner JS, Steiner JF, Corbett KK, et al. Information needs in terminal illness. Soc Sci Med 1999;48: Brown RF, Butow PN, Dunn SM, Tattersall MH. Promoting patient participation and shortening cancer consultations: a randomized controlled trial. Br J Cancer 2001;85: Hall JA, Roter DL. Patient gender and communication with physicians: results of a communitybased study. Women s Health 1995:1: Friedewald V, Buzdar AU, Bokulich M. Ask the doctor: breast cancer. Kansas City, Missouri: Andrews and McMeel, Singletary SE, Judkins AF. Breast cancer: myths and facts. New York: PRR, Inc., Appendix 1 Prompt Sheet for Breast Cancer Consultation Please check the questions that you are interested in asking your doctor. 1. What is the type and stage of my cancer? 2. Has my cancer spread? 3. If it has spread, where has it spread to and which test showed that? 4. What treatment options are available for me? 5. Do I need any more tests or procedures before my treatment? 6. How long will I be in this treatment? 7. What is the percentage of success of this treatment for the other patients? 8. How often do I need to come in to see the doctor? 9. Can I get my treatment at my local doctor s office? 10. Will the treatment have any side effects or complications? 11. What symptoms should I be alert for (i.e., fever, pain, etc.) and what should I do about these symptoms? 12. What should I do or not do when I am getting treatment, such as changing eating habits, drinking, exercising, sexual activity, and birth control? 13. If I am taking alternative medicine, can I still continue (herbs, natural foods, massage and chiropractic therapy, etc.)? 14. How and when will I know whether the treatment is working? 15. If we get rid of the cancer, what are the chances the cancer will come back? 16. What options do I have if this treatment does not work? 17. Will my family be affected by my cancer/treatment? 18. Will the treatment affect my ability to work or perform other activities? 19. Will my children have higher risk of getting cancer? 20. Can I get information on my cancer through the Internet? 21. Are there services available to help me to cope with my illness? 22. If I participate in the clinical trial will the drug company cover my treatment cost or will Medicare/Medicaid or health insurance cover the cost?

8 Vol. 25 No. 5 May 2003 Breast Cancer Prompt Sheet 419 Appendix 2 General Information Sheet for Breast Cancer Consultation General Information of Breast Cancer Treatment When a woman has been diagnosed with breast cancer, she and her team of doctors develop a comprehensive treatment plan. The plan outlines the type of surgery that will be used to remove the tumor and any additional therapy, such as radiation therapy, chemotherapy, or hormonal therapy, that will be given. There are many different types of breast cancer, so the treatment is not the same for every woman. The treatment depends upon many factors including the type of cancer cells, how much the disease has spread, and the size of the tumor. About Chemotherapy In chemotherapy, drugs are used to kill cancer cells. Chemotherapy drugs can be given by mouth, by injection, or by infusion into a vein. Chemotherapy drugs can be given in a hospital, a clinic, or a doctor s office. Most patients are able to go home between treatments and during the recovery period. Because chemotherapy affects any cell that is in the process of multiplying, normal cells may also be damaged. Chemotherapy involves the person s entire body and produces a number of side effects. One of the most feared side effects is nausea and vomiting. Fortunately, very effective medications have been developed to reduce the severity of these effects and even prevent them altogether in some patients. Other common side effects are hair loss, mouth sores, fatigue and increased chance of infections. Most side effects are temporary and go away after the chemotherapy is finished. Often chemotherapy is given with surgery, radiation therapy, or both to decrease the chance that the cancer will recur. This is done when there is a high risk that tumor cells have spread into the blood or lymph vessels. Chemotherapy given for this purpose is called adjuvant therapy. In some cases, chemotherapy is given before surgery to attempt to reduce the size of the lump and therefore make breast-conserving therapy possible. This type of chemotherapy is called neoadjuvant therapy. About Hormonal Therapy In hormonal therapy, antiestrogen drugs are used to block the effects of hormones that promote tumor growth. Estrogen is a hormone that sometimes promotes the growth of breast cancer. Hormonal therapy affects the entire body. It can cause hot flashes, excessive perspiration, vaginal itching or bleeding, temporary weight gain, nausea, and occasional depression. Not all breast cancers are sensitive to estrogen. To determine if a tumor is sensitive to estrogen, an estrogen receptor assay (also called an estrogen receptor test or ER test) is performed on cancer tissue removed at the time of surgery: a tumor sensitive to estrogen is estrogen receptor-positive, a tumor that is not sensitive is estrogen receptor-negative. Estrogen receptor positive cancers are generally more likely to respond to hormonal therapy; hormonal therapy is usually not used for estrogen receptor-negative cancers. Please circle the number that describes your feelings: Appendix 3 Patient Satisfaction Assessment 1. I am satisfied with the consult Extremely satisfied 2. The doctor was able to answer all my questions Extremely satisfied 3. The information package was helpful Extremely helpful 4. I believe the information package helped me to communicate with my doctor Extremely well 5. I will use a similar information package or write questions down before I see my doctor in the future Completely disagree Completely agree 6. Overall, I am satisfied with the way I was able to communicate with the doctor Extremely well

Vol. 29 No. 5 May 2005 Journal of Pain and Symptom Management 489

Vol. 29 No. 5 May 2005 Journal of Pain and Symptom Management 489 Vol. 29 No. 5 May 2005 Journal of Pain and Symptom Management 489 Original Article Impact of Physician Sitting Versus Standing During Inpatient Oncology Consultations: Patients Preference and Perception

More information

Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study

Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study Vol. 29 No. 6 June 2005 Journal of Pain and Symptom Management 613 Clinical Note Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study Eduardo Bruera, MD, Raul Sala,

More information

Promoting patient participation and shortening cancer consultations: a randomised trial

Promoting patient participation and shortening cancer consultations: a randomised trial doi: 10.1054/ bjoc.2001.2073, available online at http://www.idealibrary.com on http://www.bjcancer.com Promoting patient participation and shortening cancer consultations: a randomised trial RF Brown

More information

Chemotherapy Questions and Concerns: General information about what to expect

Chemotherapy Questions and Concerns: General information about what to expect Chemotherapy Questions and Concerns: General information about what to expect Princess Margaret For patients who will get chemotherapy and their families Class Overview: What is chemotherapy Side effects

More information

Transitioning to palliative care: How early is early palliative care?

Transitioning to palliative care: How early is early palliative care? Transitioning to palliative care: How early is early palliative care? Cancer: a growing problem Cancer is an increasing health care problem It is estimated that by 2020, there will be 20 million new cases

More information

CITY OF HOPE NATIONAL MEDICAL CENTER QUALITY OF LIFE QUESTIONNAIRE FOR PATIENTS WITH AN OSTOMY

CITY OF HOPE NATIONAL MEDICAL CENTER QUALITY OF LIFE QUESTIONNAIRE FOR PATIENTS WITH AN OSTOMY ID # CITY OF HOPE NATIONAL MEDICAL CENTER QUALITY OF LIFE QUESTIONNAIRE FOR PATIENTS WITH AN OSTOMY In advance, thank you for taking the time to complete this questionnaire. We want to ensure that your

More information

Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking

Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking British Journal of Cancer (1999) 80(1/2), 242 248 1999 Cancer Research Campaign Article no. bjoc.1998.0346 Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching

More information

Chemotherapy for Breast Cancer - General

Chemotherapy for Breast Cancer - General Chemotherapy for Breast Cancer - General Introduction Breast cancer is a common condition that affects one out of every 11 women. Your doctor has recommended chemotherapy for your breast cancer. Chemotherapy

More information

Cancer. University of Illinois at Chicago College of Nursing

Cancer. University of Illinois at Chicago College of Nursing Cancer University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Develop a basic understanding of cancer 2. Describe

More information

Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study

Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study Cataldo et al. BMC Cancer 2013, 13:6 RESEARCH ARTICLE Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study Open Access Janine K Cataldo 1, Steven

More information

PATIENT PERSPECTIVES: Control of Symptoms and Side Effects of Metastatic Breast Cancer. Musa Mayer AdvancedBC.org

PATIENT PERSPECTIVES: Control of Symptoms and Side Effects of Metastatic Breast Cancer. Musa Mayer AdvancedBC.org PATIENT PERSPECTIVES: Control of Symptoms and Side Effects of Metastatic Breast Cancer Musa Mayer AdvancedBC.org THE GOAL AND THE CHALLENGE Goal: Maintaining best possible quality of life, while keeping

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Small cell lung cancer (SCLC) affects 15% of all lung cancer patients. SCLC is the most aggressive type of lung cancer. It may be treated with chemotherapy and radiation. SCLC has

More information

Cancer: Questions and Answers

Cancer: Questions and Answers Cancer: Questions and Answers Key Points The survival rate for many types of cancer has improved in recent years; however, cancer is still the second leading cause of death in the United States (see paragraph

More information

An examination of the initial cancer consultation of medical and radiation oncologists using the Cancode interaction analysis system Clinical Studies

An examination of the initial cancer consultation of medical and radiation oncologists using the Cancode interaction analysis system Clinical Studies British Journal of Cancer (2008) 98, 1508 1514 All rights reserved 0007 0920/08 $30.00 www.bjcancer.com An examination of the initial cancer consultation of medical and radiation using the Cancode interaction

More information

HEDIS CAHPS 4.0H Member Survey

HEDIS CAHPS 4.0H Member Survey Helping you turn insight into action HEDIS - CAHPS 4.0H Member Survey Adult - HMO prepared for ANTHEM BLUE CROSS BLUE SHIELD - INDIA June 800.989.5150 dssresearch.com Table of Contents Background and Objectives

More information

Palliative Care in Patients with Brain Tumors: How to maintain hope and quality of life, even when treatments fail

Palliative Care in Patients with Brain Tumors: How to maintain hope and quality of life, even when treatments fail Tobias Walbert MD PhD MPH Assistant Professor Neurology Wayne State University Henry Ford Hospital Detroit twalber1@hfhs.org Palliative Care in Patients with Brain Tumors: How to maintain hope and quality

More information

Cancer Patients Interest and Preferences for an Inpatient Smoking Cessation Program (SCP)

Cancer Patients Interest and Preferences for an Inpatient Smoking Cessation Program (SCP) Cancer Patients Interest and Preferences for an Inpatient Smoking Cessation Program (SCP) Lawson Eng, Devon Alton, Yuyao Song, Jie Su, Delaram Farzanfar, Rahul Mohan, Olivia Krys, Tom Yoannidis, Robin

More information

BEHAVIORAL ASSESSMENT OF PAIN MEDICAL STABILITY QUICK SCREEN. Test Manual

BEHAVIORAL ASSESSMENT OF PAIN MEDICAL STABILITY QUICK SCREEN. Test Manual BEHAVIORAL ASSESSMENT OF PAIN MEDICAL STABILITY QUICK SCREEN Test Manual Michael J. Lewandowski, Ph.D. The Behavioral Assessment of Pain Medical Stability Quick Screen is intended for use by health care

More information

The Integrative Pain Management Program: A Pilot Clinic Serving High-Risk Primary Care Patients with Chronic Pain

The Integrative Pain Management Program: A Pilot Clinic Serving High-Risk Primary Care Patients with Chronic Pain The Integrative Pain Management Program: A Pilot Clinic Serving High-Risk Primary Care Patients with Chronic Pain IM4US CONFERENCE 25 AUGUST 2017 EMILY HURSTAK, MD, MPH, MAS SAN FRANCISCO DEPARTMENT OF

More information

Are touchscreen computer surveys acceptable to medical oncology patients?

Are touchscreen computer surveys acceptable to medical oncology patients? Southern Cross University epublications@scu School of Education 1997 Are touchscreen computer surveys acceptable to medical oncology patients? Sallie Newell Southern Cross University Rob William Sanson-Fisher

More information

At present, chemotherapy is the treatment of choice for

At present, chemotherapy is the treatment of choice for Original Article Symptom Management Strategies of Patients with Solid Cancer during Receiving Naïve Chemotherapy Phongnopakoon P, RN Abstract OBJECTIVES: The aims of the study were to evaluate patients

More information

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce Survey of disease and treatment-related t t related symptoms in outpatients with invasive i cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study, Abst # 9619) Michael J. Fisch,

More information

Patient Information Sheet

Patient Information Sheet Research Trial of Treatments for Patients with Bony Metastatic Cancer of the Prostate. - TRAPEZE Patient Information Sheet Your doctor has explained to you that your prostate cancer is no longer responding

More information

Breast Cancer Treatment

Breast Cancer Treatment Breast Cancer Treatment Treatment 2 aspects 1. Treatment of the breast itself: Local Treatment 2. Treatment of the whole body = Systemic treatment Local Treatment Surgery +/- Radiation Usually: a. Breast

More information

Communicating Title with Your Healthcare Team to Get the Care You Want. Click to edit Master text styles

Communicating Title with Your Healthcare Team to Get the Care You Want. Click to edit Master text styles Communicating Title with Your Healthcare Team to Get the Care You Want Click to edit Master text styles Lori Ranallo, Title RN, MSN, ARNP-BC, CBCN Click to edit Master text styles Breast Cancer Nurse Practitioner

More information

Palliative Care The Benefits of Early Intervention

Palliative Care The Benefits of Early Intervention The Royal Marsden Palliative Care The Benefits of Early Intervention Dr Anna-Marie Stevens, Nurse Consultant Symptom Control and Palliative Care Team, The Royal Marsden NHS Foundation Trust, London, UK

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

A GLOBAL PERSPECTIVE: MEANING, COPING, AND HEALTH OF YOUNGER AND OLDER WOMEN WITH BREAST CANCER

A GLOBAL PERSPECTIVE: MEANING, COPING, AND HEALTH OF YOUNGER AND OLDER WOMEN WITH BREAST CANCER A GLOBAL PERSPECTIVE: MEANING, COPING, AND HEALTH OF YOUNGER AND OLDER WOMEN WITH BREAST CANCER Kathleen Sternas, Ph.D, MSN, BSN, RN Seton Hall University, College of Nursing, South Orange, NJ, USA Acknowledgements

More information

For the Patient: ACTW Other names: BRAJACTW

For the Patient: ACTW Other names: BRAJACTW For the Patient: ACTW Other names: BRAJACTW A Doxorubicin (ADRIAMYCIN ) C Cyclophosphamide T Paclitaxel (TAXOL ) weekly Uses: BRAJACTW is a drug treatment given after breast cancer surgery (called adjuvant

More information

Breast Cancer Diagnosis, Treatment and Follow-up

Breast Cancer Diagnosis, Treatment and Follow-up Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce

More information

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide Other names: BRLATWAC BR Breast LA Locally Advanced T A C Paclitaxel

More information

Exploring rare patient behaviour with sequential analysis: an illustration

Exploring rare patient behaviour with sequential analysis: an illustration Exploring rare patient with sequential analysis: an illustration HILDE EIDE 1,2,VICENÇ QUERA 3, ARNSTEIN FINSET 2 1 Faculty of Nursing, Oslo University College, Oslo, Norway 2 Department of Behavioural

More information

Health Bites Breast Cancer. Breast Cancer. Normal breast

Health Bites Breast Cancer. Breast Cancer. Normal breast Health Bites Breast Cancer Breast Cancer Normal breast The normal breast tissue varies in size and shape. The breasts rest in front of the rib cage. The breasts are made up of fatty tissue, milk ducts

More information

Quality of Life Questionnaire for a Patient with an. Ostomy (QOL-O) Grant, M., Ferrell, B. R., Dean, G., Uman, G., Chu, D., & Krouse, R.

Quality of Life Questionnaire for a Patient with an. Ostomy (QOL-O) Grant, M., Ferrell, B. R., Dean, G., Uman, G., Chu, D., & Krouse, R. Instrument Title: Quality of Life Questionnaire for a Patient with an Ostomy (QOL-O) Instrument Author: Grant, M., Ferrell, B. R., Dean, G., Uman, G., Chu, D., & Krouse, R. Cite instrument as: Grant, M.,

More information

Early Integration of Palliative Care

Early Integration of Palliative Care Early Integration of Palliative Care Dr. Camilla Zimmermann Head, Palliative Care Program University Health Network Toronto November 1, 2014 www.fpon.ca Early Integration of Palliative Care: Evidence and

More information

Renewing Intimacy & Sexuality after Gynecologic Cancer

Renewing Intimacy & Sexuality after Gynecologic Cancer Renewing Intimacy & Sexuality after Gynecologic Cancer foundationforwomenscancer.org Over 90,000 women are diagnosed with a gynecologic cancer each year. The challenge for a woman with cancer and her healthcare

More information

Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia

Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia Thomas W. LeBlanc, MD, MA, MHS, FAAHPM Associate Professor of Medicine Division

More information

Treating cancer of the endometrium. Information for patients Gynaecology

Treating cancer of the endometrium. Information for patients Gynaecology Treating cancer of the endometrium Information for patients Gynaecology We have written this leaflet to provide you with information following your diagnosis of cancer of the endometrium. We understand

More information

NCI Community Oncology Research Program Kansas City (NCORP-KC)

NCI Community Oncology Research Program Kansas City (NCORP-KC) NCI Community Oncology Research Program Kansas City (NCORP-KC) Consent Form Study Title for Study Participants: Comparing Two Dose Levels of Bupropion Versus Placebo for Sexual Desire Official Study Title

More information

Supportive Care Audit Mercy Hospital for Women - Heidelberg

Supportive Care Audit Mercy Hospital for Women - Heidelberg Supportive Care Audit 2013-2014 Mercy Hospital for Women - Heidelberg Melissa Shand Service Improvement Facilitator NEMICS July 2015 Acknowledgments Mandy Byrne NEMICS Cancer and Data Information Analyst

More information

patient decision aid advanced lung cancer

patient decision aid advanced lung cancer patient decision aid advanced lung cancer Introduction This aid is meant to supplement conversations with your care team. Patients who have used a decision aid like this said it helped them make care choices

More information

Treatment for early pancreatic cancer

Treatment for early pancreatic cancer 13 11 20 Information and support Treatment for pancreatic cancer Contents Treatment for early pancreatic cancer Surgery What to expect after surgery Neoadjuvant and adjuvant therapies Treatment for advanced

More information

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:... Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -

More information

Clinical Utility of a Chemotherapy-Toxicity Prediction Tool for Elderly Cancer Patients in a Community Oncology Setting The GO trial

Clinical Utility of a Chemotherapy-Toxicity Prediction Tool for Elderly Cancer Patients in a Community Oncology Setting The GO trial Clinical Utility of a Chemotherapy-Toxicity Prediction Tool for Elderly Cancer Patients in a Community Oncology Setting The GO trial FHA Research Week 2017 Caroline Mariano Medical Oncologist, RCH Clinical

More information

National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health

National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health Breast Cancer Prevention & Detection National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health Pre-test Disclaimer This study was funded by the Institute for Research

More information

Paclitaxel (Taxol) and carboplatin

Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) Lengacher, C. A., Reich, R. R., Paterson, C. L., Ramesar, S., Park, J. Y., Alinat, C., &... Kip, K. E. (2016). Examination of broad symptom improvement resulting from mindfulness-based

More information

BROUGHT TO YOU BY. Breast Cancer

BROUGHT TO YOU BY. Breast Cancer BROUGHT TO YOU BY Breast Cancer October 2016 Breast Cancer In This Issue: } Raise Your Breast Cancer Awareness } CAM Treatments for Breast Cancer } Can Medications Help Prevent Breast Cancer? Raise Your

More information

I MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER. care guidelines

I MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER. care guidelines I MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER care guidelines Hi, Being diagnosed with breast cancer is tough at any age, but being diagnosed when you re young makes

More information

Esophageal Cancer. Source: National Cancer Institute

Esophageal Cancer. Source: National Cancer Institute Esophageal Cancer Esophageal cancer forms in the tissues that line the esophagus, or the long, hollow tube that connects the mouth and stomach. Food and drink pass through the esophagus to be digested.

More information

Information for Patients Receiving Radiation Therapy: External Beam Treatment for Prostate Cancer

Information for Patients Receiving Radiation Therapy: External Beam Treatment for Prostate Cancer Patient & Family Guide 2018 Information for Patients Receiving Radiation Therapy: External Beam Treatment for Prostate Cancer www.nscancercare.ca Information for Patients Receiving Radiation Therapy: External

More information

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin) For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin) Other names: UBRAJTTW U Undesignated BR Breast AJ Adjuvant T Trastuzumab (HERCEPTIN ) TW Paclitaxel

More information

Improving the letters we write: an exploration of doctorðdoctor communication in cancer care

Improving the letters we write: an exploration of doctorðdoctor communication in cancer care British Journal of Cancer (1999) 80(3/4), 427 437 1999 Cancer Research Campaign Article no. bjoc.1998.0374 Improving the letters we write: an exploration of doctorðdoctor communication in cancer care D

More information

Patient Intake Assessment Tools for Navigation

Patient Intake Assessment Tools for Navigation Patient Intake Assessment Tools for Navigation Review and utilize the following with new patient referrals to the Navigation program: Psychosocial Distress Screening Tool : Commission on Cancer Standard

More information

Development and pilot testing of a comprehensive support package for bowel cancer survivors

Development and pilot testing of a comprehensive support package for bowel cancer survivors Development and pilot testing of a comprehensive support package for bowel cancer survivors Michael Jefford, Carl Baravelli, Megan Rogers, Penelope Schofield, Kerryann Lotfi-Jam, Meinir Krishnasamy, Carmel

More information

Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team

Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN Cancer Survivorship Resources and Tools for the Multidisciplinary Team Your survivorship care plan is a summary of your tumor treatments and recommendations for

More information

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Weekly standard dose. Paclitaxel (Taxol) and carboplatin paclitaxel (taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Breast cancer. In this fact sheet: Breast cancer: English

Breast cancer. In this fact sheet: Breast cancer: English Breast cancer: English Breast cancer This information is about breast cancer and treatments for breast cancer. Any words that are underlined are explained in the word list at the end. If you have any questions,

More information

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine. Bendamustine Bendamustine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

Patient information. A scientific investigation of two different schedules of radiotherapy to patients operated for breast cancer

Patient information. A scientific investigation of two different schedules of radiotherapy to patients operated for breast cancer Patient information A scientific investigation of two different schedules of radiotherapy to patients operated for breast cancer Protocol title: Moderately hypofractionated loco-regional adjuvant radiation

More information

Comprehensive Assessment with Rapid Evaluation and Treatment: Integrating palliative care into the care of patients with advanced cancer Leslie J

Comprehensive Assessment with Rapid Evaluation and Treatment: Integrating palliative care into the care of patients with advanced cancer Leslie J Comprehensive Assessment with Rapid Evaluation and Treatment: Integrating palliative care into the care of patients with advanced cancer Leslie J Blackhall MD MTS Section Head, Palliative Care University

More information

Should I Continue Getting Mammograms? -For Women Age 85 or older-

Should I Continue Getting Mammograms? -For Women Age 85 or older- Should I Continue Getting Mammograms? -For Women Age 85 or older- This is a tool to help you make this decision. You will need a pen/pencil to complete parts of this tool. Copyright 2013 by Beth Israel

More information

Objectives 4/20/2018. Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer. Outpatient Consultation Service

Objectives 4/20/2018. Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer. Outpatient Consultation Service Function 4/20/2018 Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer Kim Bland, DNP, APRN-NP, FNP, AOCN Objectives Discuss Complex Illness Support Review rationale

More information

Patient Information Series PI 79. Look Good...Feel Better. Relaxation classes. beauty workshops The Way Ahead

Patient Information Series PI 79. Look Good...Feel Better. Relaxation classes. beauty workshops The Way Ahead a patient s guide Lynda Jackson Macmillan Centre... supporting people affected by cancer... Drop-in centre for support and information Telephone helpline Complementary therapies* Counselling* Benefits

More information

After Soft Tissue Sarcoma Treatment

After Soft Tissue Sarcoma Treatment After Soft Tissue Sarcoma Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Happens After Treatment for Soft Tissue Sarcomas?

More information

American Society of Clinical Oncology June , New Orleans

American Society of Clinical Oncology June , New Orleans American Society of Clinical Oncology June 5-8 2004, New Orleans The 2004 annual meeting of the American Society of Clinical Oncology (ASCO) was held June 5 8 in New Orleans, Louisiana. This conference

More information

Passport to Health Preventing and Recognizing Gynecologic Cancers

Passport to Health Preventing and Recognizing Gynecologic Cancers Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can

More information

CANCER AND YOU. Carolyn Taylor: Global Focus on Cancer

CANCER AND YOU. Carolyn Taylor: Global Focus on Cancer Carolyn Taylor: Global Focus on Cancer CANCER AND YOU This document was produced through a collaboration between Global Oncology, THE MEME, and Botswana Oncology Global Outreach (BOTSOGO) QUESTIONS ABOUT

More information

Cancer Education and Screening Programs 2018

Cancer Education and Screening Programs 2018 Lakeshore Region Cancer Network Chicago, Illinois Cancer and Screening Programs 2018 A Partnership with Unite Here Health Mark M. Connolly Sheila & Robert Hulseman Center for Cancer and Specialty Care

More information

Sexual Dysfunction in Women with Breast Cancer: An Internet-Based Intervention. Leslie R. Schover, PhD Department of Behavioral Science

Sexual Dysfunction in Women with Breast Cancer: An Internet-Based Intervention. Leslie R. Schover, PhD Department of Behavioral Science Sexual Dysfunction in Women with Breast Cancer: An Internet-Based Intervention Leslie R. Schover, PhD Department of Behavioral Science SEXUAL PROBLEMS RANK HIGH AMONG UNMET NEEDS OF SURVIVORS SEXUAL PROBLEMS

More information

Pentostatin (Nipent )

Pentostatin (Nipent ) Pentostatin (Nipent ) Pentostatin (Nipent ) This leaflet is offered as a guide to you and your family. Your treatment will be fully explained by your doctor or nurse, who will be happy to answer any questions.

More information

2012 AAHPM & HPNA Annual Assembly

2012 AAHPM & HPNA Annual Assembly in the Last 2 Weeks of Life: When is it Appropriate? When is it Not Appropriate? Disclosure No relevant financial relationships to disclose AAHPM SIG Presentation Participants Eric Prommer, MD, FAAHPM

More information

SURVEY OF MAMMOGRAPHY PRACTICE

SURVEY OF MAMMOGRAPHY PRACTICE Study ID SURVEY OF MAMMOGRAPHY PRACTICE This survey takes about 10-15 minutes to complete. We realize how busy you are and greatly appreciate your time. Your input can help make a difference in mammography.

More information

MANAGING SIDE EFFECTS

MANAGING SIDE EFFECTS MANAGING SIDE EFFECTS 94 Managing Side Effects Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by Charles L. Loprinzi, MD The Mayo Clinic Rochester, Minnesota

More information

CHEMOTHERAPY. What should I expect?

CHEMOTHERAPY. What should I expect? CHEMOTHERAPY What should I expect? WHAT IS CHEMOTHERAPY? Chemotherapy is treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemotherapy

More information

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets ChIVPP ChIVPP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment

Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment Overview What is the immune system? What are immune checkpoint inhibitors? What are the side effects to look out for? How are side effects

More information

Testicular Cancer: Questions and Answers. Testicular cancer is a disease in which cells become malignant (cancerous) in one or both testicles.

Testicular Cancer: Questions and Answers. Testicular cancer is a disease in which cells become malignant (cancerous) in one or both testicles. CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Testicular Cancer: Questions

More information

The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers. Key Points

The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s The Study of Tamoxifen

More information

Variations in Patients Self-Report of Pain by Treatment Setting

Variations in Patients Self-Report of Pain by Treatment Setting 444 Journal of Pain and Symptom Management Vol. 25 No. 5 May 2003 Original Article Variations in Patients Self-Report of Pain by Treatment Setting Cielito C. Reyes-Gibby, DrPH, Linda L. McCrory, RN, and

More information

Unmet supportive care needs in Asian women with breast cancer. Richard Fielding Division of Behavioural Sciences School of Pubic Health, HKU

Unmet supportive care needs in Asian women with breast cancer. Richard Fielding Division of Behavioural Sciences School of Pubic Health, HKU Unmet supportive care needs in Asian women with breast cancer Richard Fielding Division of Behavioural Sciences School of Pubic Health, HKU Service Access and affordability Remoteness Insurance coverage

More information

Self-Administered Stress Management Training in Patients Undergoing Radiotherapy Mindy M. Krischer, Ping Xu, Cathy D. Meade, and Paul B.

Self-Administered Stress Management Training in Patients Undergoing Radiotherapy Mindy M. Krischer, Ping Xu, Cathy D. Meade, and Paul B. VOLUME 25 NUMBER 29 OCTOBER 10 2007 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Self-Administered Stress Management Training in Patients Undergoing Radiotherapy Mindy M. Krischer, Ping Xu,

More information

After Adrenal Cancer Treatment

After Adrenal Cancer Treatment After Adrenal Cancer Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. Lifestyle Changes After Treatment for Adrenal Cancer

More information

Mon - Fri: 8.30am 4.30pm If you have any questions or concerns at all about this. 24 hour Acute Oncology Service

Mon - Fri: 8.30am 4.30pm If you have any questions or concerns at all about this. 24 hour Acute Oncology Service Radium-223 therapy Patient Information Series PI 79 East and North Hertfordshire NHS Trust 2 Contacts Who can I contact about this treatment? If you have any questions or concerns at all about this treatment

More information

Edinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF)

Edinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF) Introduction This booklet has been designed to help you and your family understand more about the chemotherapy that you are about to have as treatment for your cancer. If you need more information or have

More information

SUMMARY. Research hypotheses:

SUMMARY. Research hypotheses: SUMMARY Nephrotic syndrome is one of the most, chronic kidney disease in Egypt. The estimated incidence of nephrotric syndrome ranges between 2-7 childhood cases per 100,000 children per year. Childhood

More information

A Guide for Women with Breast Cancer

A Guide for Women with Breast Cancer INFORMATION SHEET The sheet has information about diagnosis, treatment, practical support and the emotional impact of breast cancer. We hope this information sheet will answer some of your questions and

More information

Myeloma Haematology and Transplant Unit CTD1

Myeloma Haematology and Transplant Unit CTD1 CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) FOCUSED QUESTION In persons with chronic obstructive pulmonary disease (COPD), is a combination of exercise and activity-based breathing training more effective than a

More information

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer)

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer) Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer) The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour. Myocet Myocet This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Update from the 25th Annual San Antonio Breast Cancer Symposium December 11 14, 2002

Update from the 25th Annual San Antonio Breast Cancer Symposium December 11 14, 2002 Update from the 25th Annual San Antonio Breast Cancer Symposium December 11 14, 2002 Nearly 5,000 physicians, oncologists, radiologists, epidemiologists, basic scientists, and breast cancer advocates from

More information

Gemcitabine and carboplatin (Breast)

Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Palliative Care Asking the questions that matter to me

Palliative Care Asking the questions that matter to me Palliative Care Asking the questions that matter to me THE PALLIATIVE HUB Adult This booklet has been developed by the Palliative Care Senior Nurses Network and adapted with permission from Palliative

More information

Considerations of Healthcare Professionals in Medical Decision-Making About Treatment for Clinical End-Stage Cancer Patients

Considerations of Healthcare Professionals in Medical Decision-Making About Treatment for Clinical End-Stage Cancer Patients Vol. 28 No. 4 October 2004 Journal of Pain and Symptom Management 351 Original Article Considerations of Healthcare Professionals in Medical Decision-Making About Treatment for Clinical End-Stage Cancer

More information

Wellness along the Cancer Journey: Palliative Care Revised October 2015

Wellness along the Cancer Journey: Palliative Care Revised October 2015 Wellness along the Cancer Journey: Palliative Care Revised October 2015 Chapter 3: Addressing Cancer Pain as a part of Palliative Care Palliative Care Rev. 10.8.15 Page 360 Addressing Cancer Pain as Part

More information

Tamoxifen Tamoxifen. Your treatment Your doctor or nurse clinician has prescribed for you a treatment which includes the hormonal therapy tamoxifen.

Tamoxifen Tamoxifen. Your treatment Your doctor or nurse clinician has prescribed for you a treatment which includes the hormonal therapy tamoxifen. Tamoxifen Tamoxifen This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people hormonal therapy may reduce the risk of cancer coming back, for others

More information

Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer

Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer 98 Journal of Pain and Symptom Management Vol. 45 No. June Original Article Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer

More information

Quality of Life Instrument - Breast Cancer Patient Version

Quality of Life Instrument - Breast Cancer Patient Version NATIONAL MEDICAL CENTER AND BECKMAN RESEARCH INSTITUTE Dear Colleague: Quality of Life Instrument - Breast Cancer Patient Version The Quality of Life Instrument (BREAST CANCER PATIENT VERSION) is a forty-six

More information

Visual Guide To Breast Cancer

Visual Guide To Breast Cancer Breast Cancer Today Breast cancer today is not what it was 20 years ago. Survival rates are climbing, thanks to greater awareness, more early detection, and advances in treatment. For roughly 200,000 Americans

More information